172 related articles for article (PubMed ID: 34186161)
1. Tumor infiltrating and peripheral CD4
Jacquier A; Lambert T; Delattre JF; Djouadou M; Vérine J; Dumont C; Desgrandchamps F; Carosella ED; LeMaoult J; Rouas-Freiss N
Cancer Lett; 2021 Oct; 519():105-116. PubMed ID: 34186161
[TBL] [Abstract][Full Text] [Related]
2. CD8
Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets.
Tronik-Le Roux D; Sautreuil M; Bentriou M; Vérine J; Palma MB; Daouya M; Bouhidel F; Lemler S; LeMaoult J; Desgrandchamps F; Cournède PH; Carosella ED
Cancer Immunol Immunother; 2020 Jul; 69(7):1237-1252. PubMed ID: 32166404
[TBL] [Abstract][Full Text] [Related]
4. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
5. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.
Brugière O; Mouren D; Trichereau J; Vallée A; Kuzniak I; Hirschi S; Renaud-Picard B; Reynaud-Gaubert M; Nieves A; Bunel V; Messika J; Demant X; Macey J; Le Pavec J; Dauriat G; Saint-Raymond C; Falque L; Mornex JF; Tissot A; Foureau A; Borgne Krams AL; Bousseau V; Magnan A; Picard C; Roux A; Carosella E; LeMaoult J; Rouas-Freiss N;
J Heart Lung Transplant; 2022 May; 41(5):626-640. PubMed ID: 35181243
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
Front Immunol; 2020; 11():608614. PubMed ID: 33505397
[TBL] [Abstract][Full Text] [Related]
7. First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F; Bole-Richard E; LeMaoult J; Escande M; Lecomte M; Certoux JM; Souque P; Garnache F; Adotevi O; Langlade-Demoyen P; Loustau M; Caumartin J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737343
[TBL] [Abstract][Full Text] [Related]
8. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
9. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
[TBL] [Abstract][Full Text] [Related]
10. CD4
Perugino CA; Kaneko N; Maehara T; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Della-Torre E; Murphy SJH; Ghebremichael M; Wallace ZS; Bolster MB; Harvey LM; Mylvaganam G; Tuncay Y; Liang L; Montesi SB; Zhang X; Tinju A; Mochizuki K; Munemura R; Sakamoto M; Moriyama M; Nakamura S; Yosef N; Stone JH; Pillai S
J Allergy Clin Immunol; 2021 Jan; 147(1):368-382. PubMed ID: 32485263
[TBL] [Abstract][Full Text] [Related]
11. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
12. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function.
Ince MN; Harnisch B; Xu Z; Lee SK; Lange C; Moretta L; Lederman M; Lieberman J
Immunology; 2004 Aug; 112(4):531-42. PubMed ID: 15270723
[TBL] [Abstract][Full Text] [Related]
14. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
15. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
17. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4⁺ T cells and macrophages.
Lombardelli L; Aguerre-Girr M; Logiodice F; Kullolli O; Casart Y; Polgar B; Berrebi A; Romagnani S; Maggi E; Le Bouteiller P; Piccinni MP
J Immunol; 2013 Oct; 191(7):3651-62. PubMed ID: 23997222
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
19. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
20. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.
Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A
Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
